The Orthobiologics Research Initiative recently earned a grant from the Maryland Stem Cell Research Fund, according to an Oct. 25 news release from Regenerative Orthopedics.
ROSM will conduct a two-year trial concluding in 2026 that explores the efficacy of microfat stem cells in treating rotator cuff injuries. The research will focus on noninvasive solutions and could reduce the need for surgical intervention in rotator cuff injuries, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
